Efficiency of Chinese medicines
Chinese medicine | Dosage | Duration (day) | Outcomes | References |
---|---|---|---|---|
Lianhua Qingwen granules | 6 g/pack, one pack/time, thrice a day | 7 | The clinical symptoms of COVID-19 were improved significantly, laboratory tests showed significant improvement, the cases treated with Lianhua Qingwen granules had a higher improve rate of computed tomography (CT) manifestation, no adverse effects related to Lianhua Qingwen granules were noted | [185, 187, 188, 191] |
10 | The clinical symptoms of COVID-19 were improved significantly and reduced the rate of case deterioration, no severe adverse events related to Lianhua Qingwen granules were noted | [190] | ||
14 | The treatment with Lianhua Qingwen granules showed a significantly higher recovery rate and lower deterioration rate, accelerated the recovery time of clinical symptoms, improved CT manifestation significantly; the most common adverse event was the elevated alanine aminotransferase (ALT) levels or aspartate aminotransferase levels | [192] | ||
Jinhua Qinggan granules | 10 g/time, thrice a day | 5 | The clinical symptoms of COVID-19 were significantly improved and the rate of cases deteriorated was lowerAdverse effects: diarrhea | [196] |
6 g/time, twice a day | 7 | Accelerated the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding and pneumonia recovery, increased the clearance rate of SARS-CoV-2 | [197] | |
Qingfei Paidu decoction | One dose daily, thrice a day | 9 | Clinical symptoms and pneumonia were improved, the test of the nucleoid acid of SARS-CoV-2 showed negative | [199] |
One dose daily, twice a day | 9 | Clinical symptoms disappeared, CT manifestation improved, the test of the nucleoid acid of SARS-CoV-2 showed negative, the two cases were cured and discharged | [200] | |
Laboratory tests showed significant improvement. 41.13% cases were curedAdverse effects: 4 cases occurred nausea and vomit, 2 cases had dizziness, and 1 case had rash during the treatment | [201] | |||
3 doses a treatment course | Higher rate of cured cases, accelerated the improved time of clinical symptoms and CT manifestations, reduced the rate of cases deteriorated and adverse eventsAdverse effect: nausea | [202] | ||
Huopu Xialing decoction | One cell with 150 mL warm water a time, thrice a day | 6 | Clinical symptoms of COVID-19 disappeared, the repeat test for SARS-CoV-2 nucleoid acid showed negative, the case was discharged for isolation and observation | [204] |
Shuanghuanglian oral liquid | 20 mL per time, thrice a day | 9 | Clinical symptoms disappeared, CT manifestation images showed pneumonia improved | [206] |
Shufeng Jiedu capsule | 2.08 g/time, thrice a day | 10 | Accelerated the improved time of clinical symptoms and the time for nucleoid acid of SARS-CoV-2 turned negative significantly, increased the rate of cases cured and discharged | [211] |
14 | White blood cell count and the percentage of lymphocytes were increased significantly, the duration time of fever was shortened, and pneumonia was improved significantly with a higher total effective rateAdverse effects: 1 case appeared drug allergy, 2 cases appeared abdominal pain and diarrhea | [213] | ||
XiYanPing injection | 100 mg into liquid intravenously | 10 | Clinical symptoms were improved, blood oxygen saturation values were normalized, CT manifestations showed pneumonia were improved, 2 consecutive viral nucleoid acid tests showed negative, patients were discharged at last | [223] |
XueBiJing injection | The concentration is 500 mg/mL, 100 mL per time, twice a day | 7 | Improved pneumonia significantly, alleviated the increased level of inflammatory cytokines induced by COVID-19 | [214] |
Improved inflammatory status and pneumonia significantly, shortened the time virus nucleoid acid turned negative, decreased the number of severe patients significantly | [215, 217] | |||
ReDuNing injection | 20 mL intravenously in drip | 5–7 | Improved inflammatory status significantly, shortened the time of hospitalization and the duration time in ICU | [221] |